Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2523]

First mutation-targeted bladder cancer drug may be under-used

First mutation-targeted bladder cancer drug may be under-used

PARP inhibitor treatment potential for some prostate cancer brain metastases

PARP inhibitor treatment potential for some prostate cancer brain metastases

Immunotherapy after bladder cancer surgery shows excellent cancer-free survival rates

Immunotherapy after bladder cancer surgery shows excellent cancer-free survival rates

Obesity associated with a higher risk of fatal prostate cancer, biggest study of its kind finds

Obesity associated with a higher risk of fatal prostate cancer, biggest study of its kind finds

Study identifies causes of cancer

Study identifies causes of cancer

Artificial intelligence helps physicians better assess the effectiveness of bladder cancer treatment

Artificial intelligence helps physicians better assess the effectiveness of bladder cancer treatment

Less prostate cancer screening reduces overdiagnosis but may miss aggressive cases

Less prostate cancer screening reduces overdiagnosis but may miss aggressive cases

A new pathway to shrink cancerous tumours through body’s immune cells

A new pathway to shrink cancerous tumours through body’s immune cells

Gene change explains chemo resistance in germ cell cancer

Gene change explains chemo resistance in germ cell cancer

Enfortumab vedotin approved for locally advanced or metastatic urothelial cancer

Enfortumab vedotin approved for locally advanced or metastatic urothelial cancer

More from ecancer